ALB vs ALL Stock Comparison

Scores Breakdown

Metric	ALB	ALL
📈 Growth	27/30	5/30
💰 Profitability	15/20	14/20
🏦 Financial Health	18/20	19/20
💵 Valuation	14/20	13/20
⚠️ Risk (lower is better)	7/10	6/10
Overall Score	77/100	55/100

Side-by-Side Summaries

ALB Analysis	ALL Analysis
📈 Growth & Financial Trajectory Across eight quarters, ALBEMARLE shows modest revenue growth from about $1.43B in 2024-Q2 to $1.74B in 2026-Q2, a gain of ~22%. Net income evolved from a loss of about -$176.6M to a positive $499.2M in 2026-Q2, with a mid-2025 dip, then a clear recovery into 2026. 💰 Margins & Cash Flow Gross margin expanded from a negative figure in 2024-Q2 to roughly 35% in 2025-Q1 and remained around the high 30% into 2026. Operating leverage benefited from higher margin production in later quarters. Net cash flow from operating activities, continuing, stayed strong, with $709.997M in 2026-Q2 and positive quarterly cash generation overall. Free cash flow was primarily consumed by investing activities, which were negative but the company still reported a positive overall cash flow in 2026-Q2. 🛡️ Balance Sheet & Liquidity Total assets of about $15.9B and equity of ~$10.5B support a solid balance sheet. Current assets of roughly $3.9B and current liabilities of $1.89B yield a healthy current ratio around 2.1x. Long-term debt remains moderate at about $1.88B, keeping balance-sheet risk contained. ⚠️ Key Drivers & Risks Drivers: Lithium/alloy battery demand; EV and energy-storage deployment Risks: commodity-price cyclicality; execution/valuation sensitivity to macro conditions	📈 Growth & Financial Trajectory In 8 quarters from 2024Q3 to 2026Q2, revenues rose from about $16.63B to $18.60B, an ~12% gain. Net income attributable to parent declined from ~$4.10B to ~$3.27B, a ~20% drop, signaling earnings volatility despite top-line growth. The trajectory shows strengthening revenue in late 2025–2026 and more stable earnings thereafter. 💰 Margins & Cash Flow Gross margin ranged from roughly 5% (late 2024) to the low- to mid-20s (mid-2025 and 2026), averaging in the low teens. This reflects varying underwriting costs and benefit exposure. Operating cash flow from continuing activities was consistently positive, roughly between $1.9B and $3.6B per quarter, with a notable uptick in 2025–2026. Cash flow from investing/financing centers fluctuated but overall remained manageable within the liquidity framework. Leverage remains modest with long‑term debt around $7.5B and solid equity backing. 🛡️ Balance Sheet & Liquidity Current assets consistently exceed current liabilities (roughly $115B–$126B vs. $91B–$93B), supporting liquidity. Equity sits in the high tens of billions, and Long-term Debt remains modest, indicating resilience and room to absorb shocks. ⚠️ Key Drivers & Risks Drivers: Insurance pricing and underwriting discipline; Investment income resilience. Risks: Underwriting volatility and catastrophe loss risk; Interest-rate/valuation sensitivity and reserve adequacy.

ALB Analysis

ALL Analysis

📈 Growth & Financial Trajectory

Across eight quarters, ALBEMARLE shows modest revenue growth from about $1.43B in 2024-Q2 to $1.74B in 2026-Q2, a gain of ~22%. Net income evolved from a loss of about -$176.6M to a positive $499.2M in 2026-Q2, with a mid-2025 dip, then a clear recovery into 2026.

💰 Margins & Cash Flow

Gross margin expanded from a negative figure in 2024-Q2 to roughly 35% in 2025-Q1 and remained around the high 30% into 2026. Operating leverage benefited from higher margin production in later quarters. Net cash flow from operating activities, continuing, stayed strong, with $709.997M in 2026-Q2 and positive quarterly cash generation overall. Free cash flow was primarily consumed by investing activities, which were negative but the company still reported a positive overall cash flow in 2026-Q2.

🛡️ Balance Sheet & Liquidity

Total assets of about $15.9B and equity of ~$10.5B support a solid balance sheet. Current assets of roughly $3.9B and current liabilities of $1.89B yield a healthy current ratio around 2.1x. Long-term debt remains moderate at about $1.88B, keeping balance-sheet risk contained.

⚠️ Key Drivers & Risks

Drivers: Lithium/alloy battery demand; EV and energy-storage deployment
Risks: commodity-price cyclicality; execution/valuation sensitivity to macro conditions

📈 Growth & Financial Trajectory

In 8 quarters from 2024Q3 to 2026Q2, revenues rose from about $16.63B to $18.60B, an ~12% gain. Net income attributable to parent declined from ~$4.10B to ~$3.27B, a ~20% drop, signaling earnings volatility despite top-line growth. The trajectory shows strengthening revenue in late 2025–2026 and more stable earnings thereafter.

💰 Margins & Cash Flow

Gross margin ranged from roughly 5% (late 2024) to the low- to mid-20s (mid-2025 and 2026), averaging in the low teens. This reflects varying underwriting costs and benefit exposure.
Operating cash flow from continuing activities was consistently positive, roughly between $1.9B and $3.6B per quarter, with a notable uptick in 2025–2026. Cash flow from investing/financing centers fluctuated but overall remained manageable within the liquidity framework.
Leverage remains modest with long‑term debt around $7.5B and solid equity backing.

🛡️ Balance Sheet & Liquidity

Current assets consistently exceed current liabilities (roughly $115B–$126B vs. $91B–$93B), supporting liquidity. Equity sits in the high tens of billions, and Long-term Debt remains modest, indicating resilience and room to absorb shocks.

⚠️ Key Drivers & Risks

Drivers: Insurance pricing and underwriting discipline; Investment income resilience.
Risks: Underwriting volatility and catastrophe loss risk; Interest-rate/valuation sensitivity and reserve adequacy.

Similar Companies

TSLA Score: 64

Top Rated Companies

View Top 20 →

MU "MICRON TECHNOLOGY INC"

AVGO "Broadcom Inc."

KMI "KINDER MORGAN, INC."

MNST "Monster Beverage Corp"

NEM "NEWMONT Corp /DE/"